Lafayette, IN, United States of America

Curtis M Sharkey

This inventor holds 1 USPTO granted patent. Top assignee: Purdue Research Foundation. Active years: 2006.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Curtis M Sharkey: Innovator in Retroviral Research

Introduction

Curtis M Sharkey is a notable inventor based in Lafayette, IN (US). He has made significant contributions to the field of retroviral research, particularly in the development of innovative pseudotyped retroviruses. His work has implications for various applications in virology and gene therapy.

Latest Patents

Curtis M Sharkey holds 1 patent for his invention titled "Pseudotyped retroviruses and stable cell lines for their production." This patent describes cells that produce inventive pseudotyped retroviruses with a broad host range. The cells are capable of producing retroviruses pseudotyped with at least two different viral glycoproteins, including togaviral and filoviral glycoproteins. The patent also outlines methods for producing these cells and the pseudotyped retroviruses, as well as methods for screening agents that block viral entry into cells. Additionally, it includes methods for using the pseudotyped retroviruses to introduce nucleotide sequences into target cells.

Career Highlights

Curtis M Sharkey is associated with the Purdue Research Foundation, where he continues to advance his research in retroviral technologies. His work has been instrumental in enhancing the understanding of viral mechanisms and developing new therapeutic strategies.

Collaborations

Throughout his career, Curtis has collaborated with esteemed colleagues such as Richard J Kuhn and David A Sanders. These collaborations have further enriched his research and contributed to the advancement of the field.

Conclusion

Curtis M Sharkey's innovative work in the realm of pseudotyped retroviruses showcases his dedication to advancing scientific knowledge and technology. His contributions are vital for future developments in virology and gene therapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…